ADVANCES IN ANTI-TUBERCULOSIS DRUGS

Authors

  • Sapna Pradhan Dept of Pharmacology Army College of Medical Sciences Delhi Cantt-110010
  • A G Mathur Dept of Pharmacology Army College of Medical Sciences Delhi Cantt-110010
  • Amol Patil Dept of Pharmacology Army College of Medical Sciences Delhi Cantt-110010

Abstract

Despite the introduction 40 years ago of the inexpensive and effective four-drug (isoniazid, rifampicin, pyrazinamide and ethambutol) treatment regimen, tuberculosis (TB) continues to cause considerable morbidity and mortality worldwide. For the first time since the 1960s, new and novel drugs and regimens for all forms of TB are emerging. Such regimens are likely to utilize both repurposed drugs and new chemical entities, and several of these regimens are now progressing through clinical trials. This article covers current concepts and recent advances in TB drug discovery and development.

Key Words: MDR-TB, XDR-TB, TDR-TB, Bedaquiline, Delamanid

 

DOI

https://doi.org/10.22270/jddt.v4i5.965

Published

2014-09-14
Statistics
Abstract Display: 518
PDF Downloads: 680

How to Cite

1.
Pradhan S, Mathur AG, Patil A. ADVANCES IN ANTI-TUBERCULOSIS DRUGS. J. Drug Delivery Ther. [Internet]. 2014 Sep. 14 [cited 2026 Jan. 22];4(5):69-73. Available from: https://jddtonline.info/index.php/jddt/article/view/965

Issue

Vol. 4 No. 5 (2014): Volume 4, Issue 5, Sep-Oct, 2014

Section

Review

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

How to Cite

1.
Pradhan S, Mathur AG, Patil A. ADVANCES IN ANTI-TUBERCULOSIS DRUGS. J. Drug Delivery Ther. [Internet]. 2014 Sep. 14 [cited 2026 Jan. 22];4(5):69-73. Available from: https://jddtonline.info/index.php/jddt/article/view/965
Crossref
Scopus
Google Scholar
Europe PMC